Magnetoencephalography (MEG) is one of the medical neuroimaging techniques which tracks the brain activity by measuring the magnetic field produced by neurons in the brain. It is a non-invasive technique which is safe, radiation-free, and also can be used for the pediatric population MEG device consists of numerous and highly sensitive magnetometers called Superconducting Quantum Interface Device (SQUID). MEG tests can be used for diagnosing diseases such as Alzheimer’s disease, epilepsy, and brain tumors.
It also offers real-time resolution as it is capable of providing results in milliseconds and identifies the primary location of brain activation. A MEG device captures brain activity by detecting and amplifying magnetic signals produced by the brain, and it does not emit radiation or create magnetic fields in the surrounding
Market Dynamics
Increasing awareness and diagnosis of mental illness or brain injury is expected to boost growth of the global magnetoencephalography market over the forecast period. According to the National Institute of Mental Health (NIMH), in 2016, around 44.7 million people of 18 years of age and above in the U.S. suffered from mental health disorders, and around 19.2 million people were diagnosed and received treatment.
However, factors such as low availability of MEG devices is expected to hinder growth of the magnetoencephalography devices market over the forecast period. For instance, in 2015, the European MEG Society (EMEGS) surveyed 44 MEG centers in 10 different countries, of which only 12 centers were using MEG for clinical purpose. Furthermore, high cost and maintenance cost of MEG device is a barrier for adoption of MEG, as single MEG device costs around US$ 2 million to US$ 3 million.
Key features of the study:
- This report provides in-depth analysis of the magnetoencephalography devices market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period, 2019 – 2026, considering 2018 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
- It profiles key players in the magnetoencephalography devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, strategies and key developments.
- Key players covered as a part of this study include Compumedics Limited, Croton Healthcare, Ricoh Company, Ltd., and CTF MEG International Services LP
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The magnetoencephalography devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for magnetoencephalography devices market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Magnetoencephalography Devices Market, by Application:
-
- Clinical Applications
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Traumatic Brain Injury
- Brain Tumor
- Research Applications
- Global Magnetoencephalography Devices Market, by End User:
-
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Global Magnetoencephalography Devices Market, by Region:
- North America
- By Country:
- By Application:
-
-
-
- Clinical Applications
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Traumatic Brain Injury
- Brain Tumor
- Research Applications
-
-
-
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Application:
-
-
-
- Clinical Applications
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Traumatic Brain Injury
- Brain Tumor
- Research Applications
-
-
-
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Application:
-
-
-
-
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Traumatic Brain Injury
- Brain Tumor
-
-
-
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Application:
-
-
-
-
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Traumatic Brain Injury
- Brain Tumor
-
-
-
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Application:
-
-
-
-
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Traumatic Brain Injury
- Brain Tumor
-
-
-
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Application:
-
-
-
-
- Dementia
- Autism
- Schizophrenia
- Multiple Sclerosis
- Stroke
- Epilepsy
- Traumatic Brain Injury
- Brain Tumor
-
-
-
- Hospitals
- Imaging Centers
- Academic & Research Institutes
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Croton Healthcare
- CTF MEG International Services LP
“*” marked represents similar segmentation in other categories in the respective section.
Table of Content - Magnetoencephalography Market
